| 发布于: | Android | 转发：1 | 回复：2 | 喜欢：0 |
科学那一套在这里不管用。
疫苗赛诺菲巨头投资mRNA说明了什么？资本的嗅觉最敏锐
Sanofi bets on mRNA vaccines after covid-19 pandemic shows worth
Updated: 29 Jun 2021, 06:28 PM ISTDENISE ROLAND, The Wall Street Journal
One of the world’s biggest vaccine makers, it plans to invest some $477 million a year to catch up in the new gene-based technology
Sanofi SA said it plans to build a messenger RNA vaccine business, the latest big drugmaker to embrace the technology.
The French pharmaceutical company, one of the world’s biggest vaccine makers by sales, said Tuesday that it would invest €400 million, equivalent to $477 million, a year in mRNA vaccine research, starting immediately.
The drugmaker said it expects the investment to produce at least six new candidate vaccines in human testing by 2025.
The move is a sign of how mRNA technology, which hadn’t produced an approved product before the pandemic but is now a leading source of Covid-19 shots, is reshaping the vaccine industry.
“During the Covid-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster than ever before," Jean-François Toussaint, R&D chief at Sanofi Pasteur, the company’s vaccine division, said in a statement